GlassScriptPhysician profile
Nina Mimbs
NPI 1528529179
$1,999.45
in general payments reported to CMS, 2019-2025
14 companies · $640 in 2025
The $640 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $262 · 2024: $1,097 · 2025: $640.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $969 · Travel and Lodging: $936 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $969.45 |
| Travel and Lodging | $936.00 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $802.05 | 2024 | Gelpoint V-Path |
| Biogen, INC. | $259.43 | 2025 | Zurzuvae |
| Intuitive Surgical, INC. | $228.35 | 2025 | |
| Astellas Pharma US INC | $219.00 | 2023 | Veozah |
| Baxter Healthcare | $137.80 | 2024 | Starling System |
| Mayne Pharma Commercial LLC | $120.80 | 2024 | |
| Sumitomo Pharma America, INC. | $49.43 | 2025 | Gemtesa |
| Organon LLC | $44.95 | 2023-2025 | Nexplanon |
| Hologic Sales and Service, LLC | $41.10 | 2024-2025 | Aptima |
| Solta Medical, A Division of Bausch Health US, LLC | $24.14 | 2025 | |
| Abbvie INC. | $18.73 | 2025 | |
| Eisai INC. | $18.44 | 2023 | |
| Minerva Surgical, INC | $17.79 | 2025 | |
| Evofem Biosciences, INC. | $17.44 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nina Mimbs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.